Passage BIO, Inc. (PASG): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$47.99M
Year ended 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$47.99Mn/a2026-03-03, From 2024-01-01